We are monitoring the impact of COVID-19 on MEA Blood Brain Barrier Technologies Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4436
Share on
Share on

Middle East & Africa Blood Brain Barrier Technologies Market Research Report - By Region - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 4436
Pages: 145

The MEA Blood Brain Barrier Technologies Market is predicted to grow at a sluggish CAGR from 2021 to 2026.

Brain is one of the largest and most intricate organs in the human body. It consists of 100 billion nerves that communicate with a 100 trillion synapses. It is made up of midbrain, hindbrain, and forebrain. It is responsible for movement and thought produced by the body. It has its own security system-a filtering mechanism consisting of blood vessels which allow entry of essential nutrients at the same time blocking other substances-known as the blood-brain barrier.

Blood-brain barrier is a semi-permeable dynamic interface which separates the capillaries which carry blood to the brain and spinal cord tissue by blocking the passage of certain substances. It is formed by highly specialized endothelial cells. The vessels of the blood-brain barrier are made up of specialized endothelial cell which line brain capillaries from the vascular system which lack fenestration of pores and allow rapid exchange of molecules between vessels and tissues. The blood-brain barrier protects the neural tissue from harmful chemicals and maintains a stable environment.

However, this barrier is so effective at blocking the entry of foreign substances that it often prevents penetration of life-saving drugs to address issues like injuries and diseases. Therefore, discovery of new methods allowing the effective delivery of drugs and bio-macromolecules to the central nervous system (CNS) is of immense importance for the treatment of neurodegenerative disorders. Neurodegeneration and neuro inflammation are major events in CNS disorders like Parkinson's disease, stroke, Alzheimer's disease, and multiple sclerosis. But still, the drugs for CNS treatment, like neurotrophic factors, including BDNF, EPO (erythropoietin), and anti-inflammatory antibodies (e.g., Enbrel and Remicade), do not cross the blood-brain barrier in effective therapeutic quantities.

Growing prevalence of neurological diseases like Parkinson’s disease, meningitis, multiple sclerosis, and encephalitis, augmenting geriatric population, rising healthcare expenditure, increasing investment in R&D for the development of new drugs and delivery devices, growing awareness about healthcare, and rising number of initiatives by various governments and affiliated associations are few key factors driving the growth of the market.

On the other hand, intricate regulatory frameworks for the approval of drugs in most countries and inordinate approval time for drugs due to the insufficient knowledge of the brain are primary restraints for the growth of the market.

By geography, the market is segmented into the Middle East and Africa.

Key players in the market are Bristol-Myers Squibb Company, Pfizer, Inc., biOasia Technologies, Inc., Cypress Biosciences, Inc., Janssen Pharmaceutical N.V., Teva Pharmaceuticals Industries, Ltd., F. Hoffmann La-Roche, Ltd., Eli Lilly and Company, Fabre-Kramer Pharmaceuticals, Inc., NeuroVive Pharmaceutical AB, and ArmaGen.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Geography                 

                                5.1.1 Introduction           

                                5.1.2 Middle East and Africa       

                                                5.1.2.1 Middle East

                                                5.1.2.2 Africa

                                5.1.3  Y-o-Y Growth Analysis, By Geography        

                                5.1.4  Market Attractiveness Analysis, By Geography      

                                5.1.5  Market Share Analysis, By Geography       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Allon Therapeutics, Inc.                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AngioChem Inc.                        

                8.3 Genzyme                    

                8.4 CeNeRx BioPharma, Inc                        

                8.5 Bioasis Technologies Inc.                      

                8.6 Ablynx NV                   

                8.7 Capsulution Pharma AG                        

                8.8 International Brain Barriers Society (IBBS)                     

                8.9 Cephalon Inc                              

                8.10 Cognition Pharmaceuticals LLC                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Blood Brain Barrier Technologies Market  By Geography, From 2021 to 2026 (USD Million)
  2. Middle East and Africa  Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa  Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa  Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East and Africa  Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East and Africa  Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East Blood Brain Barrier Technologies Market  By Geography, From 2021 to 2026 (USD Million)
  8. Africa Blood Brain Barrier Technologies Market  By Geography, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample